When patients were categorized by histological tumor subtype, ENO1 was expressed in tumor cells in 76.9% of ESCC cases and in 81.5% in EAC cases, and in matched normal tissues in 7.8% and 11.1%, respectively. Here, ENO1 is linked to neoplasm.